Projects per year
Fingerprint
Dive into the research topics where Sandrine Aspeslagh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
FWOAL1208: Breaking the cycle: investigating recurrent relapses in VL-HIV co-infected patients, their role in transmission and novel therapeutic strategies
Aspeslagh, S. (Administrative Promotor)
1/01/26 → 31/12/29
Project: Fundamental
-
FWOSB161: FORX - FOod interventions to Reduce immunotherapy toXicity
Verhaert, M. (Mandate) & Aspeslagh, S. (Administrative Promotor)
1/11/23 → 31/10/28
Project: Fundamental
-
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer
van Dijk, E. J., Smeenk, M. M., Bensch, F., Sadowksa, A. M., Verschueren, M. V., Verhaert, M., Llobell, A., Suzuki, Y., Liew, D. F. L., Takeji, A., Maria, A. T. J., Peters, B. J. M., Morillo, J. S. G., Chatzidionysiou, K., Lidar, M., van der Hout, E. C., Aspeslagh, S., Herder, G. J. M., van de Garde, E. M. W. & Hendriks, L. E. L. & 4 others, , Feb 2026, In: ESMO Open. 11, 2, 9 p., 106052.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Acquired hemophilia due to immune checkpoint inhibitors: a case series introducing emicizumab treatment
Wolff, L., Ertl, C., Heinzerling, L., Aspeslagh, S., Verhaert, M., Lattenist, R., Confente, C., Lambert, C. & Ilzkovitz, M., 1 Oct 2025, In: Oncologist. 30, 10, 4 p., oyaf260.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)12 Downloads (Pure) -
Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes
Mariette, X., Borchmann, S., Aspeslagh, S., Szekanecz, Z., Charles-Schoeman, C., Schreiber, S., Choy, E., Peyrin-Biroulet, L., Schmalzing, M., Tanaka, Y., ten Cate, H., Westhovens, R., van der Woude, C., Omoruyi, E., Faes, M., Masior, T., Van Hoek, P., Watson, C., Rudolph, C. & Stallmach, A., 4 Mar 2025, In: RMD open. 11, 1, 14 p., e005033.Research output: Contribution to journal › Article › peer-review
Open AccessFile9 Citations (Scopus)2 Downloads (Pure) -
Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: should we treat beyond two years?
Decruyenaere, A., Christine, G., Sylvie, R., Annouschka, L., Seront, E., Everaert, E., Debruyne, P. R., Van Den Bulck, H., Bastin, J., Annelies, V., Vulsteke, C., Schatteman, P., Luyten, D., Aspeslagh, S., Martinez-Chanza, N., De Bock, M., Meyskens, T., Verheezen, J., Brouwers, B. & Beuselinck, B., 30 Jul 2025, In: Acta Oncologica. 64, p. 979-988 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)11 Downloads (Pure) -
Three-year analysis of the Belgian multidisciplinary immunotoxicity (BITOX) board: organization, feasibility, and results
Verhaert, M., Aydogan, Y. & Aspeslagh, S., 28 Apr 2025, In: ESMO Real World Data and Digital Oncology. 8, p. 1-6 6 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure)
Activities
-
Presentatie omtrent FORX
Aspeslagh, S. (Speaker)
6 Aug 2025Activity: Talk or presentation › Talk at a festival/exhibition
-
Centre for Primary Immunodeficiency Ghent
Aspeslagh, S. (Participant)
9 Oct 2025Activity: Participating in or organising an event › Participation in conference
-
What’s new in immunomodulation
Aspeslagh, S. (Invited speaker)
26 Sept 2025Activity: Talk or presentation › Talk or presentation at a conference
-
BITOX session
Aspeslagh, S. (Speaker)
21 Nov 2025 → 22 Nov 2025Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
2025 ASCO Annual Meeting
Aspeslagh, S. (Participant), Cleo, B. (Participant), Dirven, I. (Participant) & Decoster, L. (Participant)
30 May 2025 → 3 Jun 2025Activity: Participating in or organising an event › Participation in conference
Thesis
-
3-YEAR ANALYSIS OF THE BELGIAN MULTIDISCIPLINARY IMMUNOTOXICITY (BITOX) BOARD
Aydogan, Y. ((PhD) Student), Verhaert, M. (Co-promotor) & Aspeslagh, S. (Co-promotor), 10 Jun 2024Student thesis: Master's Thesis
-
Pharmacological adaptations to immunosuppressive therapy in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors
Cappelle, C. A. ((PhD) Student), Wuyts, S. (Co-promotor), Verhaert, M. (Co-promotor), Cortoos, P.-J. (Co-promotor) & Aspeslagh, S. (Promotor), 2022Student thesis: Master-after-master